by admin | Feb 2, 2016 | Archive
February 02, 2016 FDA has approved sumatriptan (Onzetra Xsail—Avanir Pharmaceuticals) for the treatment of migraines. The drug is delivered in powder form using the novel Xsail breath-powered delivery device. “The system allows the medication to be deposited... by admin | Feb 2, 2016 | Archive
February 02, 2016 The results of a cost analysis show that, while more expensive to implement, an innovative approach for treating early schizophrenia produces improved outcomes that justify the financial premium. Sanctioned by federal authorities, the protocol is... by admin | Feb 2, 2016 | Archive
February 02, 2016 CVS Health unveiled on Monday a plan in which it will make naloxone available without a prescription at all CVS Pharmacy locations in Ohio starting in late March. Joining the company in making the announcement were White House National Drug Control... by admin | Feb 2, 2016 | Archive
February 02, 2016 Epidural anesthesia can negatively affect neonates, according to University of Granada investigators. Based on their retrospective analysis of more than 2,600 infants born between 2010 and 2013 at a single hospital in Spain, resuscitation was... by admin | Feb 2, 2016 | Archive
February 02, 2016 Traditional pharmaceutical manufacturing processes often leave military and civilian patient populations and health care providers at a disadvantage. Fortunately, advances in technology such as continuous-flow synthesis and biological engineering can... by admin | Feb 2, 2016 | Archive
February 02, 2016 The Generic Pharmaceutical Association (GPhA) has applauded progress at the federal level on issues affecting it, including a hearing of the Senate Committee on Health, Education, Labor and Pensions (HELP). The session—centered around the Generic...